It is, perhaps, an unsual move; from an organisation which fought for patients to one which often faces accusations of acting against their interests.
The new head of the pharmaceutical industry association believes that we should take part in more clinical trials. He talks to Helen Puttick.
It is, perhaps, an unsual move; from an organisation which fought for patients to one which often faces accusations of acting against their interests.